EAN 2025 | Selecting the most appropriate treatment for patients with migraine
Marina Romozzi, MD, PhD(c), Agostino Gemelli University Hospital Foundation IRCCS, Rome, Italy, gives guidance for selecting the most appropriate treatment for patients with migraine. Dr Romozzi emphasizes the importance of considering various factors, including patient choice, route of administration, treatment schedule, and comorbidities, to make an informed decision. This interview took place at the 11th Congress of the European Academy of Neurology (EAN 2025) in Helsinki, Finland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
This is a very important question at this moment because the treatment landscape for migraine has really expanded in recent years. In particular, now we have monoclonal antibodies against CGRP and we have also gepants. So it is very difficult when we have a patient that is eligible for this advanced treatment to choose which one we have to start. And so this is the moment for us to really do a tailored treatment...
This is a very important question at this moment because the treatment landscape for migraine has really expanded in recent years. In particular, now we have monoclonal antibodies against CGRP and we have also gepants. So it is very difficult when we have a patient that is eligible for this advanced treatment to choose which one we have to start. And so this is the moment for us to really do a tailored treatment. So we have to consider, of course, several factors because the clinical trials and real-world studies have also demonstrated a comparable efficacy of all these molecules. So when we have to really tailor the treatment, we should consider several aspects, including, for example, the patient’s choice, which is very important. But also, we could consider other characteristics of the molecules, for example, the route of administration, also the patient’s choice, because the patient can prefer, for example, IV administration or maybe an oral treatment. And also, we should consider the treatment schedule. We should consider also the characteristics of the patients, like for example, the comorbidities, or for example, if they want to plan a pregnancy. And so we have to choose considering all these factors.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
